title: Epigenetic changes through DNA methylation contribute to uterine stromal cell decidualization.
abstract: Embryo-uterine interaction during early pregnancy critically depends on the coordinated expression of numerous genes at the site of implantation. The epigenetic mechanism through DNA methylation (DNM) plays a major role in the control of gene expression, although this regulatory event remains unknown in uterine implantation sites. Our analysis revealed the presence of DNA methyltransferase 1 (Dnmt1) in mouse endometrial cells on the receptive d 4 of pregnancy and early postattachment (d 5) phase, whereas Dnmt3a had lower abundant expression. Both Dnmt1 and Dnmt3a were coordinately expressed in decidual cells on d 6-8. 5-Methycytosine showed a similar expression pattern to that of Dnmt1. The preimplantation inhibition of DNM by 5-aza-2'-deoxycytodine was not antagonistic for embryonic attachment, although endometrial stromal cell proliferation at the site of implantation was down-regulated, indicating a disturbance with the postattachment decidualization event. Indeed, the peri- or postimplantation inhibition of DNM caused significant abrogation of decidualization, with concomitant loss of embryos. We next identified decidual genes undergoing alteration of DNM using methylation-sensitive restriction fingerprinting. One such gene, Chromobox homolog 4, an epigenetic regulator in the polycomb group protein family, exhibited hypomethylation in promoter DNA and increased expression with the onset of decidualization. Furthermore, inhibition of DNM resulted in enhanced expression of hypermethylated genes (Bcl3 and Slc16a3) in the decidual bed as compared with control, indicating aberration of gene expression may be associated with DNM-inhibition-induced decidual perturbation. Overall, these results suggest that uterine DNM plays a major role for successful decidualization and embryo development during early pregnancy.
authors.affiliation: Division of Reproductive Sciences and Perinatal Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
authors.forename: Fei
authors.initials: F
authors.lastname: Gao
authors.forename: Xinghong
authors.initials: X
authors.lastname: Ma
authors.forename: Allison
authors.initials: A
authors.lastname: Rusie
authors.forename: Jennifer
authors.initials: J
authors.lastname: Hemingway
authors.forename: Alicia B
authors.initials: AB
authors.lastname: Ostmann
authors.forename: Daesuk
authors.initials: D
authors.lastname: Chung
authors.forename: Sanjoy K
authors.initials: SK
authors.lastname: Das
mesh_terms: D000818:Animals; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D018899:CpG Islands; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000378:metabolism; D019175:DNA Methylation; D000090205:DNA Methyltransferase 3A; D003656:Decidua / Q000473:pathology*; D000077209:Decitabine; D044127:Epigenesis, Genetic; D005260:Female; D051379:Mice; D011247:Pregnancy; D011270:Pregnancy, Animal; D011401:Promoter Regions, Genetic; D017154:Stromal Cells / Q000166:cytology*; D014599:Uterus / Q000166:cytology / Q000473:pathology*
chemical_list: C000715535:Dnmt3a protein, mouse; D000077209:Decitabine; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A; C000619381:Dnmt1 protein, mouse; D001374:Azacitidine